Medicare Enrolled
Dr. Kenneth Sha, M.D.
Pulmonary Disease · Flushing, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sha
Dr. Kenneth Sha is a pulmonary disease specialist in Flushing, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Sha performed 1,448 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sha received a total of $24,624 from 46 pharmaceutical and/or device companies across 1105 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 29% volume in NY
$24,624 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,448
Medicare services
Top 29% in NY for pulmonary disease
Not available
Unique patients (not deduplicated)
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
589 | $79 | $150 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
251 | $35 | $180 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
152 | $40 | $100 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
151 | $54 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $114 | $239 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
53 | $100 | $200 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
26 | $67 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $142 | $310 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
24 | $17 | $65 |
| Venipuncture for blood draw Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older. |
23 | $15 | $40 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
20 | $33 | $60 |
| Annual depression screening | 19 | $22 | $23 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
18 | $28 | $239 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
14 | $580 | $1,500 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
11 | $143 | $209 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$24,624
Total received (2018-2024)
Avg $3,518/year across 7 years
Top 10% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
1,105
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,778
2023
$4,101
2022
$3,937
2021
$4,028
2020
$2,414
2019
$3,503
2018
$2,864
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$664
GlaxoSmithKline, LLC.
$545
Mallinckrodt Hospital Products Inc.
$529
Boehringer Ingelheim Pharmaceuticals, Inc.
$367
Regeneron Healthcare Solutions, Inc.
$311
Insmed, Inc.
$304
Amgen Inc.
$209
Baxter Healthcare
$156
Electromed, Inc.
$152
Actelion Pharmaceuticals US, Inc.
$139
Philips North America LLC
$103
Mylan Specialty L.P.
$69
GENZYME CORPORATION
$68
Takeda Pharmaceuticals U.S.A., Inc.
$66
Phathom Pharmaceuticals, Inc.
$51
Merck Sharp & Dohme LLC
$25
Genentech USA, Inc.
$21
Top 3 companies account for 46.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,974
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,755
AstraZeneca Pharmaceuticals LP
$2,739
Mallinckrodt Hospital Products Inc.
$2,429
Regeneron Healthcare Solutions, Inc.
$1,509
Actelion Pharmaceuticals US, Inc.
$1,205
Insmed, Inc.
$1,156
Genentech USA, Inc.
$872
Electromed, Inc.
$763
Amgen Inc.
$599
Mylan Specialty L.P.
$593
Sunovion Pharmaceuticals Inc.
$581
Philips Electronics North America Corporation
$545
Baxter Healthcare
$404
Novo Nordisk Inc
$342
Mallinckrodt Enterprises LLC
$330
Teva Pharmaceuticals USA, Inc.
$321
Advanced Respiratory, Inc
$315
Takeda Pharmaceuticals U.S.A., Inc.
$208
Lilly USA, LLC
$200
AbbVie Inc.
$175
United Therapeutics Corporation
$158
OptiNose US, Inc.
$124
ANI Pharmaceuticals, Inc.
$117
Philips North America LLC
$103
Circassia Pharmaceuticals Inc
$99
GENZYME CORPORATION
$93
PFIZER INC.
$88
Janssen Pharmaceuticals, Inc
$82
Shire North American Group Inc
$81
Bayer HealthCare Pharmaceuticals Inc.
$80
ABBVIE INC.
$78
Merck Sharp & Dohme LLC
$71
Merck Sharp & Dohme Corporation
$58
ADVANCED RESPIRATORY, INC
$55
Phathom Pharmaceuticals, Inc.
$51
Inogen, Inc.
$44
JAZZ PHARMACEUTICALS INC.
$44
Melinta Therapeutics, LLC
$40
Mallinckrodt LLC
$34
Jazz Pharmaceuticals Inc.
$24
Grifols USA, LLC
$21
Kowa Pharmaceuticals America, Inc.
$20
Gilead Sciences, Inc.
$17
Hikma Pharmaceuticals USA
$16
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 42.5% of all-time payments
Associated products mentioned in payments ›
(2535) Sleep Service · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · Adempas · AirDuo Digihaler · Arikayce · ArmonAir Digihaler · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · Baxdela · CHANTIX · CINQAIR · CREON · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DreamWear · DreamWear Pillows · ELIQUIS · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · InogenOne · JARDIANCE · KEYTRUDA · KRYSTEXXA · LINZESS · LONHALA MAGNAIR · Letairis · Life 2000 Ventilation System · Livalo · MOUNJARO · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolastin-C · QVAR · Respiratoriy Care Undiv · Ryaltris · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TAGRISSO · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TYVASO · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Tresiba · Trilogy 100 · UPTRAVI · UTIBRON · Utibron · VOQUEZNA · Verquvo · Victoza · Wellcentive Undiv · XARELTO · Xhance · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
659
County median income
$84,961
Nearest hospital to ZIP centroid (approximate)
NEW YORK-PRESBYTERIAN/QUEENS
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sha is a clinical cardiology specialist, with above-average Medicare volume (top 29% in NY), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sha experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Sha performed 589 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sha receive payments from pharmaceutical companies?
Yes. Dr. Sha received a total of $24,624 from 46 companies across 1,105 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sha's costs compare to other pulmonary diseases in Flushing?
Dr. Sha's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Flushing
Browse pulmonary diseases in Flushing ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology